Skip to main content

Quality Management of Steroid Hormone Assays

  • Chapter
  • First Online:
Steroid Analysis

Abstract

This chapter describes the principles and practices of quality management of the steroid hormone in clinical laboratory service, and the assessment of the quality of that service by the author’s EQA programme (UK NEQAS for Steroid Hormones).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Barnard G, Kohen F (1990) Idiometric assay: noncompetitive immunoassay for small molecules typified by the measurement of oestradiol in serum. Clin. Chem. 36; 1945–1950.

    CAS  Google Scholar 

  • Büttner J (1991) Philosophy of measurement by means of immunoassays. Scand. J. Clin. Lab. Invest. 51 (Suppl 205); 11–20.

    Article  Google Scholar 

  • Cawood ML, Field HP, Ford CG, Gillingwater S, Kicman A, Cowan D, Barth JH (2005) Testosterone measurement by isotope-dilution liquid chromatography-tandem mass spectrometry: validation of a method for routine clinical practice. Clin. Chem. 51, 1472–1479.

    Article  CAS  Google Scholar 

  • de Verdier CH, Groth T, Petersen PH (eds) (1993) Medical Need for quality specifications in clinical laboratories. Upsala J. Med. Sci. 98(3); 189–498.

    Article  Google Scholar 

  • Ekins R (1983) The precision profile: its use in assay design, assessment and quality control. In Immunoassays for Clinical Chemistry (eds Hunter WM, Corrie JET). Churchill-Livingstone, Edinburgh. pp. 76–105.

    Google Scholar 

  • Ekins R (1991a) Immunoassay standardisation. Scand. J. Clin. Lab. Invest. 51(Suppl 205); 33–46.

    Article  Google Scholar 

  • Ekins R (1991b) Immunoassay design and optimisation. In Principles and Practice of Immunoassay (eds Price C, Newman D), Chapter 5. Macmillan, London. pp. 96–153.

    Google Scholar 

  • Ekins RP, Chu R, Biggart E (1990) The development of microspot, multi-analyte, ratiometric immunoassay using dual fluorescent-labelled antibodies. Anal. Chim. Acta. 227; 73–96.

    Article  Google Scholar 

  • EU Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices (1998-12-07 OJ No L 331/1).

    Google Scholar 

  • Fraser CG (1983) Desirable performance standards for clinical chemistry tests. Adv. Clin. Chem. 23; 299–339.

    Article  CAS  Google Scholar 

  • Fraser CG, Hyltoft-Petersen P (1993a) Desirable standards for laboratory tests if they are to fulfil medical needs. Clin. Chem. 39; 1447–1455.

    CAS  Google Scholar 

  • Fuentes-Aderiu X (2000) Trueness and Uncertainty website guest essay at www.westgard.com/guest15.htm

  • Gosling JP (1991) Standardisation of immunoassays for Hapten analytes. Scand. J. Clin. Lab. Invest. 51 (Suppl 205); 95–104.

    Article  Google Scholar 

  • Gosling JP, Middle JG, Siekmann L, Read GF (1993) Standardisation of Hapten immunoprocedures: total cortisol. Scand. J. Clin. Lab. Invest. 53 (Suppl 216); 3–41.

    Article  CAS  Google Scholar 

  • Hammond GL (1990) Molecular properties of corticosteroid binding globulin and the sex steroid binding proteins. Endocr.Rev. 11; 65–79.

    Article  CAS  Google Scholar 

  • Healy MJR (1979) Outliers in clinical chemistry quality control schemes. Clin. Chem. 25; 675–677.

    CAS  Google Scholar 

  • Herold DA, Fitzgerald RL (2003) Immunoassays for testosterone in women: better than a guess? Clin. Chem. 49; 1250–1251.

    Article  CAS  Google Scholar 

  • Hyltoft Petersen P, Horder M (1992) Influence of analytical quality on test results. Scand. J. Clin. Lab. Invest. 52 (Suppl 208); 65–67.

    Article  Google Scholar 

  • Jeffcoate SL (1981) Efficiency and Effectiveness in the Clinical Laboratory. Academic, London.

    Google Scholar 

  • Kane J, Middle J, Cawood M (2007) Measurement of serum testosterone in women; what should we do? Ann. Clin. Biochem. 44; 5–15.

    Article  CAS  Google Scholar 

  • Kushnir MM, Rockwood AL, Roberts WL, Pattison EG, Bunker AM, Fitzgerald RL, and Meikle AW (2006) Performance characteristics of a novel tandem mass spectrometry assay for serum testosterone. Clin. Chem. 52; 120–128.

    Article  CAS  Google Scholar 

  • Libeer J-CPM (1993) External Quality Assessment in Clinical Laboratories – European perspectives: today and tomorrow. Ph.D. thesis, University of Antwerp, Belgium.

    Google Scholar 

  • Middle JG (1998) Standardisation of steroid hormone assays. Ann. Clin. Biochem. 35; 354–363.

    Article  CAS  Google Scholar 

  • Middle JG (2007) Dehydroepiandrostenedione sulphate interferes in many direct immunoassays for testosterone. Ann. Clin. Biochem. 44; 173–177.

    Article  CAS  Google Scholar 

  • Middle JG, Libeer JC, Malakhov V, Penttilä I (1998) Characterisation and evaluation of external quality assessment scheme serum. Discussion Paper from the European External Quality Assessment (EQA) Organisers Working Group C. Clin. Chem. Lab. Med. 36; 119–130.

    Article  CAS  Google Scholar 

  • Panteghini M (2007) Traceability, reference systems and result comparability. Clin. Biochem. Rev. 28; 97–104.

    Google Scholar 

  • Ratcliffe WA, Carter GD, Dowsett M, Hillier SG, Middle JG, Reed MJ (1988) Oestradiol assays: applications and guidelines for the provision of a clinical biochemistry service. Ann. Clin. Biochem. 25; 466–483.

    Article  CAS  Google Scholar 

  • Ricos C, Arbos MA (1990) Quality goals for hormone testing. Ann. Clin. Biochem. 27; 353–358.

    Article  CAS  Google Scholar 

  • Ricós C, Iglesias N, García-Lario JV, Simón M, Cava F, Hernández A, Perich C, Minchinela J, Alvarez V, Doménech MV, Jiménez CV, Biosca C, Tena R (2007) Within-subject biological variation in disease: collated data and clinical consequences. Ann. Clin. Biochem. 44; 343–352.

    Article  Google Scholar 

  • Ritchie RF (1991) Immunoanalytical standardization – a global science. Scand. J. Clin. Lab. Invest. Suppl. 205; 3–10.

    Article  CAS  Google Scholar 

  • Selby C (1990) Sex hormone binding globulin: origin, function and clinical significance. Ann. Clin. Biochem. 27; 532–541.

    Article  Google Scholar 

  • Seth J, Hanning I (1988) Factors associated with the quality of laboratory performance in the United Kingdom external quality assessment scheme for serum growth hormone. Clin. Chim. Acta. 174; 185–196.

    Article  CAS  Google Scholar 

  • Stanczyk FZ, Lee JS, Santen RJ. (2007) Standardization of steroid hormone assays: why, how, and when? Cancer Epidemiol. Biomarkers Prev. Sep; 16(9);1713–1719.

    Article  CAS  Google Scholar 

  • Taieb J, Mathian B, Millot F, Patricot MC, Mathieu E, Queyrel N, Lacroix I, Somma-Delpero C, Boudou P (2003) Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin. Chem. 49; 1381–1395.

    Article  CAS  Google Scholar 

  • Thienpont LM, Van Uytfanghe K, De Leenheer AP (2002) Reference measurement systems in clinical chemistry. Clin. Chim. Ada. 323; 73–87.

    Article  CAS  Google Scholar 

  • Westgard JO, Darcy T (2004) The truth about quality: medical usefulness and analytical reliability of laboratory tests. Clin. Chim. Acta. 346; 3–11.

    Article  CAS  Google Scholar 

  • Westgard JO, Petersen JH, Groth T (1984) The quality costs of an analytical process: development of quality costs models based on predicitive value theory. Scand. J. Clin. Lab. Invest. 44(Suppl 172); 221–236.

    Google Scholar 

Download references

Acknowledgments

The UK NEQAS for Steroid Hormones is funded by subscriptions from participants throughout the UK and overseas. Administrative support is provided by the staff of the Wolfson EQA Laboratory, part of the University Hospital Birmingham NHS Foundation Trust, directed by Dr. David Bullock. Scientific guidance is provided by the UK NEQAS Special Advisory Group for Immunoassay (Chair Dr. Geoff Beckett). Policy support is given by the UK NEQAS Consortium Executive (chair Mrs Barbara De La Salle). UK NEQAS could not function without the support of the National Blood Service at Birmingham, and the work of the Wolfson Computer Laboratory, University Hospital Birmingham NHS Foundation Trust, directed by Dr. Ian Clarke, in developing and maintaining the EQAS Computer System, which is warmly acknowledged.

It should be noted that Siemens Healthcare Medical Solutions have now absorbed Bayer Diagnostics and the Diagnostic Products Corporation. Therefore all references to method names such as Bayer Centaur and DPC Immulite should be understood now to mean Siemens Centaur and Siemens Immulite.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jonathan G. Middle .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Middle, J.G. (2010). Quality Management of Steroid Hormone Assays. In: Makin, H., Gower, D. (eds) Steroid Analysis. Springer, Dordrecht. https://doi.org/10.1023/b135931_13

Download citation

Publish with us

Policies and ethics